Drug class
Antimetabolite
Mechanism of action
Ribonucleotide Reductase Inhibitors
General use cases
- Brain Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Head and Neck Neoplasms
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
